Trademark: 97041301
Word
APTAH
Status Date
Monday, July 8, 2024
Filing Date
Thursday, September 23, 2021
Published for Opposition
Tuesday, November 29, 2022
5 Pharmaceutical preparations for the configuration, modulation and correction of RNA transcript splicing, capping and tailing for the treatment of genetic diseases; pharmaceutical preparations for the configuration, modulation and correction of RNA for the treatment of genetic diseases; pharmaceutical preparations for restoring and reprograming RNA-protein interactions for the treatment of genetic diseases; pharmaceutical preparations for the treatment of genetic diseases associated with gene dysregulation, inhibition or suppression of gene expression; pharmaceutical preparations for the treatment of genetic diseases; gene therapy products, namely, molecules in the nature of genetically engineered tissues for controlling gene expression; medical molecular diagnostic tests for testing bodily fluid for the detection of genetic diseases; medical diagnostic tests for the detection of neurodegenerative, oncological and infectious diseases
1 Biomolecules in the nature of gene therapy products, namely, genetically engineered stem cells in the nature of synthetic cDNAs for controlling gene expression for medical and scientific research
42 Research and development of pharmaceuticals, namely, therapies for the configuration, modulation and correction of RNA transcript splicing, capping and tailing; scientific research and development of therapies in the fields of biotechnology, genetic medicine, gene therapy, DNA, RNA, molecules and proteins; pharmaceutical products design and development in the field of biomolecules for medical and scientific use, and medical treatment; pharmaceutical drug design and development featuring biomolecules
Jun 29, 2022
Non-Final Action E-Mailed
Sep 27, 2021
New Application Entered
Oct 25, 2021
New Application Office Supplied Data Entered
Jun 24, 2022
Assigned To Examiner
Jun 29, 2022
Non-Final Action Written
Jun 29, 2022
Notification Of Non-Final Action E-Mailed
Aug 23, 2022
Teas Response To Office Action Received
Aug 23, 2022
Correspondence Received In Law Office
Aug 24, 2022
Teas/Email Correspondence Entered
Oct 6, 2022
Final Refusal Written
Oct 6, 2022
Final Refusal E-Mailed
Oct 6, 2022
Notification Of Final Refusal Emailed
Oct 7, 2022
Teas Request For Reconsideration Received
Oct 7, 2022
Correspondence Received In Law Office
Oct 7, 2022
Teas/Email Correspondence Entered
Oct 25, 2022
Approved For Pub - Principal Register
Nov 9, 2022
Notification Of Notice Of Publication E-Mailed
Nov 29, 2022
Published For Opposition
Nov 29, 2022
Official Gazette Publication Confirmation E-Mailed
Jan 24, 2023
Noa E-Mailed - Sou Required From Applicant
Jun 22, 2023
Sou Teas Extension Received
Jun 22, 2023
Sou Extension 1 Filed
Jun 22, 2023
Sou Extension 1 Granted
Jun 24, 2023
Notice Of Approval Of Extension Request E-Mailed
Jul 8, 2024
Sou Teas Extension Received
Jul 8, 2024
Notice Of Approval Of Extension Request E-Mailed
Jul 8, 2024
Sou Extension 3 Filed
Jul 8, 2024
Sou Extension 3 Granted
Jan 26, 2024
Notice Of Approval Of Extension Request E-Mailed
Jan 24, 2024
Sou Teas Extension Received
Jan 24, 2024
Sou Extension 2 Filed
Jan 24, 2024
Sou Extension 2 Granted
Trademark Alertz updated from USPTO on 2030-01-24
